Management of Differentiated Thyroid Cancer -

Management of Differentiated Thyroid Cancer

Buch | Hardcover
XIII, 320 Seiten
2017 | 1st ed. 2017
Springer International Publishing (Verlag)
978-3-319-54492-2 (ISBN)
139,09 inkl. MwSt

This text provides a comprehensive, state-of-the art review of this field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in thyroid cancer. The book reviews new data about molecular genetics and molecular diagnostic approaches, covers diagnosis and treatment of localized disease, and conventional and newer therapies for dealing with recurrent and metastatic disease. Areas of controversy, with expert opinions from both outlooks, are also covered.  

Management of Differentiated Thyroid Cancer serves as a very useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy.  It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information.

Anne T Mancino, M.D., F.A.C.S. Associate Professor, Department of Surgery University of Arkansas Chief, General Surgery Central Arkansas Veterans Healthcare System Little Rock, AR USA Lawrence T. Kim, M.D., F.A.C.S.Professor, Division of Surgical Oncology, Department of SurgeryUniversity of North Carolina170 Manning Drive1150 Physicians Office Building, CB#7213 Chapel Hill, NCUSA

The Rising Incidence of Thyroid Cancer: Contributions from Healthcare Practice and Biologic Risk Factors.- Molecular Genetics of Thyroid Cancer.- Evaluation of a thyroid nodule.- Pathologic diagnosis of thyroid cancer.- Molecular Diagnostic Approaches and their Clinical Utility.- Clinical Presentation and Diagnosis of Papillary Thyroid Cancer.- Clinical Presentation and Diagnosis of Follicular Thyroid Cancer.- Clinical Presentation and Diagnosis of Hürthle cell Thyroid Cancer.- High Risk and Poorly Differentiated Thyroid Cancer.- Pediatric Thyroid Cancer.- Active Surveillance as the Initial Course of Action in low-risk papillary microcarcinoma.- Surgical treatment of papillary and follicular thyroid cancer.- Lymph node dissection for differentiated thyroid cancer.- The Debate For Elective Lymph Node Dissection in Papillary Thyroid Carcinoma.- Debate:  Pro and Con Elective Lymph Node Dissection.- Differentiated Thyroid Cancer - Prognostic and Risk Assessment Systems.- Radioactive Iodine as Adjuvant or Systemic Treatment.- Considerations in thyrotropin stimulating hormone suppression in individuals with differentiated thyroid cancer.- IMAGING MODALITIES IN THE DIAGNOSIS OF RECURRENT OR METASTATIC THYROID CANCER.- Operative Treatment of Recurrent or Metastatic Disease.- Local and Systemic Treatment of Unresectable Disease.- Surveillance Strategies After Initial Treatment of Differentiated Thyroid Cancer.

Erscheinungsdatum
Zusatzinfo XIII, 320 p. 88 illus., 64 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 823 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Chirurgie
Medizinische Fachgebiete Innere Medizin Endokrinologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Studium
Schlagworte Cancer Staging • endocrinology • Fine needle aspiration biopsy • Follicular Thyroid • Krebs (Krankheit) / Karzinom • Medicine • Medicine: general issues • molecular genetics • neck dissection • Papillary Thyroid • Radioactive iodine • surgical oncology • Thyroid Cancer • Thyroid cancer surveillance • Thyroid chemotherapy • Thyroid pathology • Thyroid Surgery • TSH Suppression
ISBN-10 3-319-54492-6 / 3319544926
ISBN-13 978-3-319-54492-2 / 9783319544922
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Clemens Marischler

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
29,00